AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia

Recruitingn/aAges 18 Years - anyAllProf. Dr. Cemil Tascıoglu Education and Research …
💬

In plain words

What the trial is, and whether it could suit you

Postherpetic neuralgia (PHN) is a chronic pain syndrome that may be resistant to treatment and can lead to physical and social disability as well as psychological disturbances, persisting for years in some patients. Varicella zoster virus remains latent in the sensory neurons of individuals who have previously had chickenpox. Reactivation of the latent virus results in herpes zoster. Herpes zoster typically begins with dermatomal pain, followed within a few days by the development of characteristic dermatomal skin rashes. These cutaneous lesions usually resolve within 2-4 weeks; however, pain may persist even after the rash has healed. There is variability in the literature regarding the definition of PHN. The development of PHN is associated with increased central neuronal sensitization, reduced inhibitory neuronal function, inflammation and nerve injury in the peripheral nervous syste

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of postherpetic neuralgia (PHN) * No invasive or noninvasive treatment related to PHN (e.g., capsaicin, lidocaine patches) within the past 3 months * Provision of written informed consent Exclusion Criteria: * Patients with a cardiac pacemaker * Known allergy to transcutaneous electrode pads * Active skin infection at the pad application site * Presence of a metallic implant in the treatment area * Circulatory disorders or skin lesions at the treatment site * Inability to maintain appropriate positioning * Inability to communicate effectively * Presence of psychosis or progressive neurological deficits * Pregnancy
💊

What it tests

  • Transcutaneous Pulsed Radiofrequency
📍

Where

1 site
Istanbul Prof. Dr. Cemil Taşcioğlu City Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy